Clinical Trials Directory

Trials / Conditions / Hepatic Carcinoma

Hepatic Carcinoma

29 registered clinical trials studyying Hepatic Carcinoma3 currently recruiting.

StatusTrialSponsorPhase
RecruitingLaryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia
NCT07359586
Zhejiang University
RecruitingAn Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
NCT06342414
City of Hope Medical Center
UnknownA Study of Ga-68 Dolacga to Evaluate Liver Reserve Function in Patients With HCC Before and After Proton Thera
NCT06182865
National Atomic Research Institute, TaiwanN/A
UnknownEfficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoacti
NCT06085976
Clinica Universidad de Navarra, Universidad de NavarraPhase 2
CompletedLiver Resection for Patients With Hepatocellular Carcinoma and Clinically Significant Portal Hypertension
NCT06245798
Tang-Du Hospital
WithdrawnA Study to Evaluate Vaccines Against COVID-19 in the Real World
NCT04775056
Humanity & Health Medical Group Limited
Completedto Assess the Accuracy and Reliability of the Ga68-Dolacga Positron Emission Tomography Compared to Computer T
NCT05007548
National Atomic Research Institute, TaiwanPhase 2
UnknownESP Block on Patient Outcomes in Patients With Liver Tumor Undergoing Radiofrequency Ablation
NCT05009550
TC Erciyes UniversityN/A
Enrolling By InvitationPrehabilitation and Posttransplant Training Program in Liver Transplantation
NCT04246970
Maria dels Angels Cebria i Iranzo, PT, PhDN/A
CompletedDevelopment of a Neuronal Microscope
NCT06311396
Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoN/A
UnknownRadiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic Cancers
NCT04682847
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
UnknownA Clinical Study in Patients With High-risk Recurrent Primary Hepatocellular Carcinoma Using Autologous TILs
NCT04538313
CAR-T (Shanghai) Cell Biotechnology Co., Ltd.Phase 1 / Phase 2
Active Not RecruitingCombined Locoregional Treatment With Immunotherapy for Unresectable HCC.
NCT04220944
Shanghai Zhongshan HospitalPhase 1
CompletedArterial Base Fluorescence Segmental Positive Staining
NCT04266548
Chang Gung Memorial HospitalN/A
CompletedTransarterial Chemoembolization in Combination With Nivolumab Performed for Intermediate Stage Hepatocellular
NCT03572582
AIO-Studien-gGmbHPhase 2
UnknownThe Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by Resect
NCT03253250
Huashan HospitalPhase 4
CompletedEndoscopic Ultrasound Guided Liver Biopsy
NCT03307811
AdventHealthN/A
UnknownExhaustive Genetic and Immunological Characterization of Colon, Kidney and Liver Tumors
NCT03149523
European Georges Pompidou Hospital
UnknownImpact of Three-dimensional Visualization on Operation Strategy and Complications for Complex Hepatic Carcinom
NCT03132740
Zhujiang Hospital
CompletedHepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular
NCT03164382
Sun Yat-sen UniversityPhase 3
UnknownA Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer
NCT03013712
First Affiliated Hospital of Chengdu Medical CollegePhase 1 / Phase 2
CompletedPhase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With A
NCT02834780
H3 Biomedicine Inc.Phase 1
CompletedTransradial Versus Transfemoral Arterial Access in Liver Cancer Embolization: Randomized Trial to Assess Patie
NCT03163186
Medical University of South Carolina
CompletedPercutaneous Irreversible Electroporation for Unresectable Hepatic Carcinoma in Poor Liver Function
NCT02352935
Fuda Cancer Hospital, GuangzhouN/A
CompletedPercutaneous Irreversible Electroporation to Treat Liver Cancer Close to the Gallbladder
NCT02332551
Fuda Cancer Hospital, GuangzhouN/A
TerminatedHuaier Granule for Prevention of Disease Progression of Hepatocarcinoma After Non-radical Hepatectomy
NCT01760616
Qidong Gaitianli Medicines Co., LtdPhase 4
CompletedHuaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma After Radical Hepatectomy
NCT01770431
Qidong Gaitianli Medicines Co., LtdPhase 4
CompletedAn Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037
NCT00884520
Siemens Molecular ImagingEARLY_Phase 1
UnknownFunctional-three-dimensional Reconstruction of Liver by 99MTc-GSA-SPECT Scan
NCT01350726
Peking Union Medical College Hospital